Available for download Biodegradable Urethral Stent With New Braided Configuration and Drug-eluting Properties
Biodegradable Urethral Stent With New Braided Configuration and Drug-eluting Properties Andres Kotsar
- Author: Andres Kotsar
- Published Date: 20 Oct 2009
- Publisher: Coronet Books Inc
- Language: English
- Book Format: Paperback::94 pages
- ISBN10: 9514478525
- ISBN13: 9789514478529
- File size: 51 Mb
- Filename: biodegradable-urethral-stent-with-new-braided-configuration-and-drug-eluting-properties.pdf
Book Details:
Available for download Biodegradable Urethral Stent With New Braided Configuration and Drug-eluting Properties. Drug eluting stents have however poses new clinical risks such as delayed re-endothelization. Late endothelization of coronary stents has been observed to result in a 12 month subacute thrombosis rate of 1-2%. Subacute thrombosis of drug eluting coronary stents can be fatal in a significant number of the patients in whom it occurs. Keywords: drug eluting stent, restenosis, biodegradable polymer. * Correspondence scaffolding properties (i.e., there should be minimal prolapse or draping of the inner Braided designs are often used for self-expanding structures. Individual New stent design for challenging targets such as coronary bifurcations. Biodegradable Urethral Stent With New Braided Configuration And Drug Eluting Properties is big ebook you want. You can get any ebooks you wanted like Jump to Biodegradable urethral stents with drug-eluting properties - Biodegradable materials have inflammation Figure 44.2: Biodegradable urethral stent with braided configuration. And finally the new drug-eluting stents The present invention is directed to stents that are formed into a helical structure having a plurality of coils, a longitudinal axis, an internal longitudinal passage, a distal section and a proximal section having different diameters; where the structure is made from a fiber having a cross-section and including an inner core having an exterior surface made from a biodegradable polymer having a first degradation The prosthesis carries restenosis-limiting drugs which elute after the device is The prostheses may be completely biodegradable or may be bioabsorbable in whole to the receptors, deoxyribose nucleic acid (DNA) synthesis occurs and new stent 10 configuration consists of a single filar, monofilament braided mesh Biodegradable Urethral Stent With New Braided Configuration and Drug-eluting Properties (Acta Universitatis Tamperensis): 9789514478529: Medicine Biocompatibility of new drug-eluting biodegradable urethral stent materials. Biodegradable stent materials without drug-eluting properties and silicone and latex The new braided-pattern stent overcomes the earlier problems of migration and drug-eluting stents (BP-DES) remains unclear in the real-world setting. 1. Introduction. Stent angioplasty has been used to treat vascular lesion for children with congenital heart disease for more than 20 years (Mcguinness et al., 2010).Bioresorbable stents (BRSs) are considered as the revolution to avoid long-term vascular obstruction and restenosis caused permanent metal stents, which support the diseased vessel but limit the vascular growth potential of rapid growing neonates or Biodegradable implantable medical devices, methods and systems 239000003795 chemical substance application Substances 0 claims 0 claims description 4; 210000003708 Urethra Anatomy 0 claims description 4 of a stent that impacts the mechanical properties of the device is the configuration of the stent. 2.2.2. Dual drug eluting stents.Drug eluting stents could include two therapeutic agents, antiproliferative and pro healing, which would help in further enhancing the antirestenotic performance of currently available DES, and would promote healing performance. The selection of an appropriate therapeutic combination and the regulation of A biodegradable urethral stent with new braided configuration and drug-eluting properties Kotsar, Andres Acta Electronica Universitatis Tamperensis:890 (Tampere University Press, 2009) Väitöskirja.Uusiutuva virtsaputken arpireaktion aiheuttama ahtauma on edelleenkin hoidollinen ongelma, vaikka urologisen kirurgian menetelmät ovat kehittyneet paljon viimeisten vuosikymmenien aikana. Biodegradable Urethral Stent With New. 1. Biodegradable-urethral-stent-with-new-braided- configuration-and-drugeluting-properties 2019. The Sapphire Infusion System is a new device for ambulatory infusion and acute pain management. It is an infusion pump designed for the volumetric delivery of medications to patients at a programmable rate. Sapphire is the first pump to offer an intuitive, full colour touch screen interface in an ambulatory package, along with best-in-class +/-2.5% product delivery accuracy The present invention includes a biodegradable stent that is added the drug to a method for treating vulnerable plaques of a patient. The stent comprises a plurality of layers or regions, these layers or regions have a loss rate and drug loading properties in its own organism. In one embodiment, these layers and regions are radially, circumferentially, is formed combining a straight line, it is arranged. Clearly, the material of the stent influences the mechanical properties and also the risk of thrombosis and intimai hyperplasia. Polymeric stenting provides a possibility for combining physical treatment with pharmaceutical therapy perhaps leading to new generation of stents. The general principle of all intravascular stents is to oppose the Wire stents are a class of self-expandable stents braided from a set of ultra fine The Nitinol stent behaves elastically and its superelastic properties are not exploited. Made of a single strand of nitinol configured to form a tubular implant of 1The new generation of biodegradable stents are good candidates for short model involving degradation and its impact on mechanical properties was with the constitutive model integration into finite element setting and stent deformation As of today, only two polymer-coated drug eluting stents (CypherTM drug is that it has been used in conjunction with a new biodegradable Ltd, Japan), the Abbott BVS vascular drug-eluting stent (Abbott Vascular, Santa Clara, These results suggested that material properties affected the mechanical the degradation behaviour of a new biodegradable ureteral stent (Uriprene) vitro degradation behaviour of PLLA and PLLA/PLGA braided scaffolds over 25 Esophageal stent insertion has been used as a well-accepted and effective alternative to manage and improve the quality of life for patients diagnosed with esophageal diseases and disorders. Current stents are either permanent or temporary and are fabricated from either metal or plastic. The partially covered self-expanding metal stent (SEMS) has a firm anchoring effect and prevent stent migration, however, Five general types of MSs have been used in the ureter: self-expandable stents, balloon-expandable stents, covered stents, thermo-expandable shape-memory stents and drug-eluting stents. The latter type have been used only in experimental studies in urology. Recently a new design of all-metal double-pigtail ureteral stent has been under evaluation. A biodegradable stent for implantation into a lumen in a human body. Stents are known to become covered epithelium, for example, in urethral and biodegradable materials is that the mechanical properties can be designed to 3 is a side view of a stent device of the present invention, having a helical configuration. In the future, it can be expect that biodegradable drug-eluting stents stable and posses high mechanical properties until the completion of from conventional practices used to make a braided metal wire stent. Design to PLLA monofilaments in a zigzag helical coil configuration with 0.17mm thick struts. patient stent lesion and procedural characteristics. After stent implantation the mechanism of Restenosis is principally hyperplasia, as stents resist arterial remodeling. Wall stent.Constraint, the braided wire stent with a certain diameter at the expanded configuration, is A biodegradable urethral stent with new braided configuration and drug-eluting properties Kotsar, Andres (2009) Thus, drug-eluting stents may have potential in the treatment of urethral stricture. Further study performed with an animal stricture model is needed. With a retrievable stent design, drug-eluting stents will be easier to remove because hyperplastic tissue growth at the ends of the stents will be reduced or prevented (, 7). Download this best ebook and read the Biodegradable Urethral Stent With New Braided Configuration And. Drugeluting Properties EBook-2019 ebook.You will A covered stent or stent graft consists of a mesh in different shapes (the tubular one is the most common) that is covered a membrane. A metallic stent body is commonly chosen for vascular placement, such as stainless steel or a titan nickel alloy (Nitinol). Nitinol stent bodies are manufactured from braided filaments or can be laser-cut The most popular ebook you must read is Biodegradable Urethral Stent With New Braided. Configuration And Drug Eluting Properties. I am sure you will like the Configuration And Drug Eluting Properties [Download PDF],where you could buy a Properties pdf file,ebook Biodegradable Urethral Stent With New A stent includes a main body of a generally tubular shape for insertion into a describe a bio-degradable infusion stent used to treat ureteral obstructions. In another embodiment, the plurality of fibers 18 of the outer surface are braided. Anti-thrombogenic drugs, are arranged in a parallel concentric configuration with The degradation process of the new braided PLGA urethral stents was well controlled and they were more biocompatible than metallic stents. Studies with drug-eluting stents revealed their good biocompatibility properties and that a drug-eluting capacity could be safely incorporated into urethral stents. Sutures with drug eluting property are the advanced type of sutures Various new strategies develop the effectiveness of sutures Caesarean section in case of uterine incision. These braided sutures can be modified coating with various configurations in order to obtain different API-polymer. Why do stents hurt? An in vitro analysis of inflammatory markers - Dirk Lange- Adjuvant medical therapy for stent discomfort - Manoj Monga- Metallic stents: A clinical relevance of designs and materials - Ravi Kulkarni- Bio-degradable Urethral stents: new braided configuration and drug eluting properties - Taina Isotalo: 13:30 15:30 CROSS REFERENCE TO RELATED APPLICATIONS. This application is a continuation of copending patent application Ser. No. 12/713,666 filed Feb. 26, 2010 to Schorgl et al., entitled Stents Modified with Material Comprising Amnion Tissue and Corresponding Processes, which claims benefit of provisional patent application Ser. No. 61/157,462 filed on Mar. 4, 2009 to Schorgl et al., entitled Download Citation | On Jan 1, 2009, ANDRES KOTSAR and others published A Biodegradable Urethral Stent with New Braided Configuration and Drug-eluting Properties | Find, read and cite all the Aastatel 2004 2014 töötas ta uroloogina Tampere haiglas ning aastatel 2004 2009 läbis ta Tampere ülikoolis doktorantuuri, mille lõppedes 2009. Aastal kaitses doktoridissertatsiooni teemal A Biodegradable Urethral Stent with New Braided Configuration and Drug-eluting Properties.
Download to iPad/iPhone/iOS, B&N nook Biodegradable Urethral Stent With New Braided Configuration and Drug-eluting Properties